Medical Design Technology

News

Subscribe to MDT Magazine News

athenahealth Hosts Health Care Hack-a-Thon

April 29, 2013 8:45 am | by GlobeNewswire | Comments

athenahealth, Inc., a leading provider of cloud-based services for electronic health record (EHR), practice management, and care coordination, in partnership with MIT's H@cking Medicine, invites the health care, technology and scientific communities to participate in a Hack-a-Thon on May 4 and 5 at athenahealth's headquarters in Watertown, Mass.

TOPICS:

Spine Wave Announces U.S. FDA's 510K Clearance of the StaXx(R) IB System, an Intervertebral Body Fusion Device

April 29, 2013 8:00 am | by The Associated Press | Comments

Spine Wave, Inc. a privately held medical device company committed to the development and delivery of high-quality innovative medical devices for the treatment of spinal disorders, today announced that it has received 510(k) clearance from the United States Food and Drug Administration to...

TOPICS:

UK Hospitals Order All Varian TrueBeam Radiotherapy Systems Offered Under Government Stimulus Program

April 29, 2013 8:00 am | by PR Newswire | Comments

CRAWLEY, U.K., April 29, 2013 /PRNewswire/ -- Hospitals in London and Dorset have acquired the final two of ten advanced Varian Medical Systems (NYSE: VAR) radiotherapy treatment machines offered as part of an innovative government program to roll out the most modern cancer...

TOPICS:
Advertisement

Teleflex Receives FDA 510(k) Clearance for Next Generation Vascular Positioning System®

April 29, 2013 7:00 am | by The Associated Press | Comments

LIMERICK, Pa.--(BUSINESS WIRE)--Apr 29, 2013--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, announces that its ARROW ® VPS G4 ™ Device has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA). The ARROW...

TOPICS:

King Fahd Hospital of the University of Damman Chooses Nuance’s Advanced Speech Recognition

April 29, 2013 5:47 am | by The Associated Press | Comments

KHOBAR, Saudi Arabia--(BUSINESS WIRE)--Apr 29, 2013--Emerging Technologies announced today that Saudi Arabia’s King Fahd University Hospital is to implement the Nuance Healthcare Dragon Medical 360 | Network Edition hospital-wide in a bid to deliver a truly 21 st century healthcare experience. ...

TOPICS:

Class I Medical Device Recall: Hospira Inc., GemStar Infusion System, Lithium Battery - Low Voltage

April 29, 2013 12:00 am | by U.S. Food & Drug Administration | Comments

When the GemStar Lithium battery voltage level drops below 2.4 volts, an "11/004" error is displayed and the device is rendered inoperable. This failure mode results in a delay/interruption of therapy. Additionally, infusion settings and event history logs will be erased as a result of this device malfunction.

TOPICS:

Co-Diagnostics Inc. Acquires Suite of Technologies from DNA Logix

April 26, 2013 4:50 pm | by The Associated Press | Comments

SALT LAKE CITY--(BUSINESS WIRE)--Apr 26, 2013--Co-Diagnostics, Inc., a specialist in personalized medicine and clinical diagnostics, has entered into an agreement with DNA Logix, a leader in the development of molecular diagnostic assays, to acquire certain technologies for genetic analysis in the...

TOPICS:

Spanish Group Patents an Automatic Suture System for Colon Cancer Operations

April 26, 2013 3:08 pm | by Plataforma SINC | Comments

The Spanish research center Innotex has developed a device that enables automatic suturing of the large intestine after being sectioned during cancer colon surgery. The novelty of the system, called Insewing, is that it allows the use of absorbable suture material instead of metallic staples which are currently used and could cause intestinal stiffness and obstruction.

TOPICS:
Advertisement

New Imaging Technology Could Reveal Cellular Secrets

April 26, 2013 3:02 pm | by Emil Venere, Purdue University | Comments

Researchers have married two biological imaging technologies, creating a new way to learn how good cells go bad. "Let's say you have a large population of cells," said Corey Neu, an assistant professor in Purdue University's Weldon School of Biomedical Engineering. "Just one of them might metastasize or proliferate, forming a cancerous tumor. We need to understand what it is that gives rise to that one bad cell."

TOPICS:

BD Diagnostics Advances Commitment to a Fully Integrated Microbiology Solution with New Agreement

April 26, 2013 2:19 pm | by Bio-Medicine.Org | Comments

SPARKS, Md. , April 27, 2013 /- BD Diagnostics, a segment of BD (Becton, Dickinson and Company), announced today an international distributor agreement with Bruker Daltonics Inc. to sell and provide front-line technical support for the co-labeled BD™ Bruker MALDI Biotyper™ System. Microbial identification and antimicrobial susceptibility testing is the end-poin...

TOPICS:

AAHomecare and NAIMES to Merge

April 26, 2013 12:19 pm | by Bio-Medicine.Org | Comments

The American Association for Homecare ( AAHomecare ) and the National Association of Independent Medical Equipment Suppliers ( NAIMES ) have reached an agreement to merge their organizations. The combined Association will maintain the AAHomecare name and continue to do business at 1707 L Street NW, Suite 350, Washington, D.C. , 20036.

TOPICS:

Energy Efficient Brain Simulator Outperforms Supercomputers

April 26, 2013 11:02 am | by National Science Foundation | Comments

In November 2012, IBM announced that it had used the Blue Gene/Q Sequoia supercomputer to achieve an unprecedented simulation of more than 530 billion neurons. The Blue Gene/Q Sequoia accomplished this feat thanks to its blazing fast speed; it clocks in at over 16 quadrillion calculations per second.

TOPICS:

Shareholders Criticize J&J Management for Lapses

April 26, 2013 10:56 am | by Linda A. Johnson, AP Business Writer | Comments

Several Johnson & Johnson shareholders took the health care giant to task during its annual meeting Thursday, criticizing management for repeated product recalls, ethical lapses and excessive executive pay.       

TOPICS:

Cardio Could Hold Key to Cancer Cure

April 26, 2013 10:21 am | by European Association for the Study of the Liver | Comments

Regular exercise has been proven to reduce the chance of developing liver cancer in a world-first mice study that carries hope for patients at risk from hepatocellular carcinoma (HCC). The research announced at the International Liver Congress™ 2013 involved two groups of mice fed a control diet and a high fat diet then divided into separate exercise and sedentary groups.

TOPICS:

Novel Screening Tests for Liver Cancer

April 26, 2013 10:12 am | by European Association for the Study of the Liver | Comments

New data from two clinical trials presented today at the International Liver Congress™ 2013 demonstrate substantial improvements in the detection of both hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC) using diagnostic urine tests. HCC is common throughout the world and most often develops as a late complication of chronic viral hepatitis or cirrhosis of any cause.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading